JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

C6962 Lawsone

≥35.6 mg/mL
C7164 5-Methoxysalicylic acid

≥31.2 mg/mL
A9916 Fedratinib hydrochloride hydrate

Summary: A JAK2 inhibitor

insoluble in DMSO; insoluble in EtOH; insoluble in H2O
BA2403 Fomc-Gly-Gly-Phe-Gly-OH

Summary: Fomc-Gly-Gly-Phe-Gly-OH can be used as an intermediate in the synthesis of ADCdual-drug-linker.
A4447 2,3-DCPE hydrochloride

Target: Apoptosis Inducers

Summary: Bcl-XL protein expression downregulator

<30.06 mg/mL
A4465 MIM1
1 Citation

Target: Mcl-1

Summary: Mcl-1 Inhibitor

insoluble in EtOH; insoluble in H2O; ≥12.15 mg/mL
A4477 Cyclic Pifithrin-α hydrobromide

Summary: P53 inhibitor

insoluble in H2O; ≥25 mg/mL
A8221 EPZ-6438
9 Citation

Summary: EZH2 inhibitor

≥28.64 mg/mL
A8223 CID 2011756

Summary: PKD inhibitor

≥39.7 mg/mL
A1792 PD184352 (CI-1040)

Target: MEK

Summary: Selective MEK inhibitor

≥47.9 mg/mL